Literature DB >> 18158823

Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches.

Carlo Selmi1, Christopher L Bowlus, Carl L Keen, M Eric Gershwin.   

Abstract

The epidemic of non-alcoholic fatty liver disease (NAFLD) in the United States is staggering, and there is an enormous void in our understanding of the clinical epidemiology other than the common themes of obesity and insulin resistance. There is also a public health need to better define effective treatments of NAFLD, including dietary interventions and appropriate nutritional supplements. There is, however, a wealth of basic science that helps to set the stage for defining the mechanisms leading to liver pathology. In this article we will attempt to put these concepts in perspective to highlight the need for future research including the use of medicinal food.

Entities:  

Mesh:

Year:  2007        PMID: 18158823     DOI: 10.1089/jmf.2007.620

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  4 in total

Review 1.  Probiotics and immunity.

Authors:  Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2009-01-22       Impact factor: 7.527

2.  Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.

Authors:  Jia Xiao; Chi Tat Ho; Emily C Liong; Amin A Nanji; Tung Ming Leung; Thomas Yue Huen Lau; Man Lung Fung; George L Tipoe
Journal:  Eur J Nutr       Date:  2013-03-21       Impact factor: 5.614

3.  Dietary patterns and risk of non-alcoholic fatty liver disease.

Authors:  Ammar Salehi-Sahlabadi; Samaneh Sadat; Sara Beigrezaei; Makan Pourmasomi; Awat Feizi; Reza Ghiasvand; Amir Hadi; Cain C T Clark; Maryam Miraghajani
Journal:  BMC Gastroenterol       Date:  2021-01-28       Impact factor: 3.067

4.  Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study.

Authors:  Athina I Amanatidou; Andriana C Kaliora; Charalampia Amerikanou; Stefan Stojanoski; Natasa Milosevic; Chara Vezou; Mirjana Beribaka; Rajarshi Banerjee; Ioanna-Panagiota Kalafati; Ilias Smyrnioudis; Mary Jo Kurth; Aimo Kannt; M Pilar Francino; Sophie Visvikis-Siest; Panos Deloukas; Carlos Llorens; Fernando Marascio; Natasa Milic; Milica Medic-Stojanoska; Amalia Gastaldelli; Maria Giovanna Trivella; George V Dedoussis
Journal:  Int J Environ Res Public Health       Date:  2022-01-16       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.